HYOJEONG HAN to Humans
This is a "connection" page, showing publications HYOJEONG HAN has written about Humans.
Connection Strength
0.163
-
Outcomes on the use of hyperhemolysis prophylaxis in pediatric sickle cell disease patients with history of hyperhemolysis syndrome. Transfusion. 2025 May; 65(5):1001-1006.
Score: 0.026
-
Detection of novel duplication variant in ADAMTS13 gene using chromosomal microarray analysis. BMJ Case Rep. 2024 Jun 11; 17(6).
Score: 0.025
-
Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):696-703.
Score: 0.021
-
Broad-Spectrum Antibiotics Deplete Bone Marrow Regulatory T Cells. Cells. 2021 01 30; 10(2).
Score: 0.020
-
Evaluation and Management of Coagulopathies and Thrombophilias in Pediatric Patients. Clin Lab Med. 2021 03; 41(1):83-100.
Score: 0.019
-
BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney. Pediatr Blood Cancer. 2020 04; 67(4):e28151.
Score: 0.018
-
Case 6: Ascites in a 20-year-old Man with Dandy-Walker Syndrome, Hydrocephalus, and Ventriculoperitoneal Shunt. Pediatr Rev. 2017 Oct; 38(10):494-495.
Score: 0.016
-
Management of neonatal and infant aortic thrombosis: A single-center case series. Pediatr Blood Cancer. 2024 Nov; 71(11):e31283.
Score: 0.006
-
Bleeding outcomes and management of supratherapeutic episodes secondary to warfarin in children: A single center 10-year experience. Thromb Res. 2023 08; 228:148-150.
Score: 0.006
-
In vitro phosphorylation of von Willebrand factor by FAM20c enhances its ability to support platelet adhesion. J Thromb Haemost. 2019 06; 17(6):866-877.
Score: 0.004
-
Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease. Thromb Haemost. 2009 Jun; 101(6):1070-7.
Score: 0.002